Left Atrial Appendage (LAA) Occluders

This channel includes news and new technology innovations about Left Atrial Appendage (LAA) Occluders. These close off the LAA in patients with atrial fibrillation to prevent the formation of stroke-causing clots than embolize to brain.

LAA occluder, Watchman

Boston Scientific's Watchman LAA occluder device is designed to prevent stroke in patients atrial fibrillation without the need for warfarin therapy.

Feature | November 08, 2013

November 8, 2013 – According to Millennium Research Group (MRG), the anticipated Food and Drug Administration (FDA)...

Videos | November 07, 2013

Herbert Aronow, M.D., MPH, St. Joseph Mercy Hospital, Ann Arbor, and an active member of ACC and SCAI, explains the...

Lariat Suture Device Left Atrial Appendage Occluder Stroke Risk
News | July 15, 2013

July 15, 2013 — Shore University Medical Center is one of only a handful of hospitals in the country offering the...

FDA US device innovation

The delay in being able to bring new medical device advances to market in the United States, such as transcatheter aortic valves and left atrial appendage occluders, has raised the question of the U.S. leadership role in technology innovation.

Feature | July 03, 2013 | Anita Asgar, M.D., FSCAI

The field of interventional cardiology is one of constant change and innovation. The past 10 years have...

Technology | June 28, 2013

June 28, 2013 — Maquet Cardiovascular LLC announced it has acquired LAAx Inc., a privately held company that has...

Boston Scientific Watchmen Left Atrial Appendage Closure Atrial Fibrillation
Feature | May 13, 2013

May 13, 2013 — Boston Scientific reports that the four-year follow-up data from the PROTECT AF...

Simbionix ANGIO Mentor Structural Heart Simulator Models
Technology | May 02, 2013

May 2, 2013 — Simbionix USA Corp. released various training modules for the Angio Mentor endovascular simulator....

Boston Scientific Watchmen Left Atrial Appendage Closure Atrial Fibrillation
Feature | March 19, 2013

March 19, 2013 — Boston Scientific reports preliminary data in the PREVAIL clinical trial met two out of three co-...

Feature | March 13, 2013

March 13, 2013 — St. Jude Medical Inc. announced the first patient implant in a new pivotal trial evaluating the...

Amplatzer Amulet St. Jude Medical Left Atrial Appendage Occluders
Feature | January 29, 2013

January 29, 2013 — St. Jude Medical Inc. announced European CE mark approval of its Amplatzer Amulet...

News | July 06, 2012

July 6, 2012 — Boston Scientific Corp. has completed enrollment in the PREVAIL confirmatory study, designed to gain...

News | May 14, 2012

May 14, 2012 — Boston Scientific announced results from the ASA Plavix (ASAP) study, which studied the Watchman...

Videos | Left Atrial Appendage (LAA) Occluders | April 06, 2012

Siemens' AcuNav V 3-D intracardiac echo (ICE) catheter offers detailed, live 3-D images of the interior of the heart...

Feature | February 01, 2012 | Dave Fornell

Based on my observations and those of the doctors on the Diagnostic & Interventional Cardiology Editorial...

News | January 25, 2012

January 25, 2012 — Which Medical Device announced the winner of its Device of the Year Award 2011 in the cardiology...

Overlay Init